AMD - AGE-RELATED MACULAR DEGENERATION
Clinical trials for AMD - AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new AMD - AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for AMD - AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill for macular degeneration enters first human tests
Disease control Recruiting nowThis early-stage study tests an oral drug called ABF-101 in healthy adults and people with age-related macular degeneration (AMD). The main goal is to check safety and how the body processes the drug. About 68 participants will take either ABF-101 or a placebo to see if it is wel…
Matched conditions: AMD - AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1 • Sponsor: Aptabio Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Vision training may lift mood in macular degeneration patients
Symptom relief Recruiting nowThis study looks at whether a visual rehabilitation program can ease anxiety and depression in people with advanced age-related macular degeneration (AMD). Twenty-two participants will attend five group sessions over 60 days, learning skills like coin recognition, using voice ass…
Matched conditions: AMD - AGE-RELATED MACULAR DEGENERATION
Sponsor: Fondazione G.B. Bietti, IRCCS • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Eye bleeding study aims to predict who sees better after gas procedure
Knowledge-focused Recruiting nowThis study is for people with age-related macular degeneration who have bleeding under the retina. Researchers want to see if the type of abnormal blood vessel affects how well vision recovers after a gas bubble procedure to move the blood. About 60 participants will be followed …
Matched conditions: AMD - AGE-RELATED MACULAR DEGENERATION
Sponsor: Marco Mazzola • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC